Abbott Laboratories Stock Analysis

ABT Stock  USD 130.75  0.25  0.19%   
Abbott Laboratories is undervalued with Real Value of 136.1 and Target Price of 130.62. The main objective of Abbott Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Abbott Laboratories is worth, separate from its market price. There are two main types of Abbott Laboratories' stock analysis: fundamental analysis and technical analysis.
The Abbott Laboratories stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Abbott Laboratories is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Abbott Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Stock Analysis Notes

About 80.0% of the company shares are held by institutions such as insurance companies. The book value of Abbott Laboratories was presently reported as 27.52. The company recorded earning per share (EPS) of 7.64. Abbott Laboratories last dividend was issued on the 27th of December 2021. The entity had 10000:4798 split on the 30th of December 2020. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. For more info on Abbott Laboratories please contact Miles White at 224 667 6100 or go to https://www.abbott.com.

Abbott Laboratories Quarterly Total Revenue

10.97 Billion

Abbott Laboratories Investment Alerts

Over 80.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Global Neuroprosthetics Market Expanding Rapidly at a CAGR of 13 percent by 2032 Amid Surge in Demand for Advanced Neurological Treatments DelveInsight

Abbott Laboratories Upcoming and Recent Events

17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Abbott Largest EPS Surprises

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-04-19
2017-03-310.430.480.0511 
2015-04-22
2015-03-310.420.470.0511 
2014-04-16
2014-03-310.360.410.0513 
View All Earnings Estimates

Abbott Laboratories Environmental, Social, and Governance (ESG) Scores

Abbott Laboratories' ESG score is a quantitative measure that evaluates Abbott Laboratories' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Abbott Laboratories' operations that may have significant financial implications and affect Abbott Laboratories' stock price as well as guide investors towards more socially responsible investments.

Abbott Laboratories Thematic Classifications

In addition to having Abbott Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Compulsion Idea
Compulsion
Addiction driven consumer products and services
SRI Sustainable Growth Idea
SRI Sustainable Growth
Large and mid-sized companies that operate under the guidelines of socially responsible investing - SRI

Abbott Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of America Corp2021-11-18
18.8 M
Wells Fargo & Co2021-11-18
16.7 M
Bank Of New York Mellon Corp2021-11-18
13.6 M
State Farm Mutual Automobile Ins Co2021-11-18
13.6 M
Charles Schwab Investment Management Inc2021-11-18
12.9 M
Ameriprise Financial Inc2021-11-18
12.9 M
Massachusetts Financial Services Company2021-11-18
12.8 M
Polen Capital2021-11-18
12.7 M
Deutsche Bank Ag2021-11-18
12.4 M
Vanguard Group Inc2021-11-18
168.6 M
Blackrock Inc2021-11-18
136.5 M
Note, although Abbott Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Abbott Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 225.57 B.

Abbott Profitablity

The company has Net Profit Margin of 0.32 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.17 %, which entails that for every 100 dollars of revenue, it generated $0.17 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.26  0.17 
Return On Capital Employed 0.10  0.10 
Return On Assets 0.16  0.13 
Return On Equity 0.28  0.26 

Management Efficiency

Abbott Laboratories has Return on Asset of 0.0606 % which means that on every $100 spent on assets, it made $0.0606 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3091 %, implying that it generated $0.3091 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.17 in 2025. Return On Capital Employed is likely to drop to 0.1 in 2025. At this time, Abbott Laboratories' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 4.2 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 8.5 B in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 27.66  29.04 
Tangible Book Value Per Share 10.48  11.00 
Enterprise Value Over EBITDA 18.76  19.70 
Price Book Value Ratio 4.11  2.63 
Enterprise Value Multiple 18.76  19.70 
Price Fair Value 4.11  2.63 
Enterprise Value203.3 B213.4 B
Abbott Laboratories' management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Dividend Yield
0.0183
Operating Margin
0.1686
Profit Margin
0.3189
Forward Dividend Yield
0.0183
Beta
0.801

Technical Drivers

As of the 1st of May, Abbott Laboratories shows the risk adjusted performance of 0.0358, and Mean Deviation of 1.11. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Abbott Laboratories Price Movement Analysis

java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Abbott Laboratories price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Abbott Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbott Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbott Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abbott Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Abbott Laboratories Outstanding Bonds

Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Abbott Laboratories Predictive Daily Indicators

Abbott Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abbott Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Abbott Laboratories Corporate Filings

Abbott Laboratories Forecast Models

Abbott Laboratories' time-series forecasting models are one of many Abbott Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Abbott Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abbott Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abbott shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Abbott Laboratories. By using and applying Abbott Stock analysis, traders can create a robust methodology for identifying Abbott entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.17  0.21 
Operating Profit Margin 0.16  0.21 
Net Profit Margin 0.32  0.17 
Gross Profit Margin 0.55  0.62 

Current Abbott Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abbott analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
130.62Strong Buy27Odds
Abbott Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to Abbott conference calls.
Abbott Analyst Advice Details

Abbott Stock Analysis Indicators

Abbott Laboratories stock analysis indicators help investors evaluate how Abbott Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Abbott Laboratories shares will generate the highest return on investment. By understating and applying Abbott Laboratories stock analysis, traders can identify Abbott Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow6.9 B
Long Term Debt12.6 B
Common Stock Shares Outstanding1.7 B
Total Stockholder Equity47.7 B
Tax Provision-6.4 B
Quarterly Earnings Growth Y O Y0.083
Property Plant And Equipment Net10.7 B
Cash And Short Term InvestmentsB
Cash7.6 B
Accounts Payable4.2 B
Net Debt7.4 B
50 Day M A130.7194
Total Current Liabilities14.2 B
Other Operating Expenses35.1 B
Non Current Assets Total57.8 B
Forward Price Earnings25
Non Currrent Assets Other16.5 B
Stock Based Compensation673 M

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.